April 20, 2021 | Press Release

Cell and Gene Therapy Innovator Castle Creek Biosciences Appoints Matthew Gantz as President and Chief Executive Officer

Life sciences executive brings more than 25 years of experience to cell and gene therapy company progressing through pivotal Phase 3 clinical trial

Read More

March 09, 2020 | Presentations

Corporate Fact Sheet

Castle Creek Biosciences, Inc., a privately held company located in Exton, PA, is focused on developing and commercializing personalized gene therapies for patients with rare and serious genetic diseases. Castle Creek Biosciences is a portfolio company of Paragon Biosciences.

Read More